EUCTR2016-002048-18-ES
Active, not recruiting
Phase 1
Clinical Trial to determine efficacy and safety of healing with platelet-rich plasma, fibrin and leukocytes compared to standard healing with nitrofurazone ointment in subjects with onychocryptosis. - Clinical Trial to determine efficacy and safety of healing with L-PRF in Onychocryptosis Surgery.
IVERSIDAD REY JUAN CARLOS0 sites20 target enrollmentNovember 22, 2016
ConditionsTHE POST-OPERATIVE OF NAIL SURGERY WITH PHENOL 88% TECHNIQUE IN SUBJECTS WITH ONYCOCRYPTOSIS IN BOTH FIRST TOES HEALINGS WITH NITROFURAZONE OINTMENT OR LEUCOYTES, FIBRINE AND PLATELETS PLASMA CLOT.Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Therapeutic techniques [E02]
DrugsFURACIN POMADA
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- THE POST-OPERATIVE OF NAIL SURGERY WITH PHENOL 88% TECHNIQUE IN SUBJECTS WITH ONYCOCRYPTOSIS IN BOTH FIRST TOES HEALINGS WITH NITROFURAZONE OINTMENT OR LEUCOYTES, FIBRINE AND PLATELETS PLASMA CLOT.
- Sponsor
- IVERSIDAD REY JUAN CARLOS
- Enrollment
- 20
- Status
- Active, not recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- PEOPLE OVER 18 YEAR.
- •\- DIAGNOSED OF ONYCOCRYPTOSIS.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1\.2 Adults (18\-64 years) yes
- •F.1\.2\.1 Number of subjects for this age range 20
- •F.1\.3 Elderly (\>\=65 years) no
- •F.1\.3\.1 Number of subjects for this age range
Exclusion Criteria
- •\-OVER 65 YEARS.
- •\-WITH DIABETES MELLITUS.
- •\-WITH OPEN WOUNDS ON THE TOES.
- •\-WITH ALLERGICS BACKGROUND TO COMPONENTS USED.
- •\-WITH ATOPIC DERMATITIS OR OTHERS PROBLEMS IN THE SKIN OF TOES.
- •\-WITHOUT CONTROL OF SYSTEMIC DISEASES.
- •\-WITH PERIPHERAL VASCULAR DISEASE.
- •\-WITHOUT MOTOR OR COGNITIVE CAPACITY.
- •\-WITH ANTICOAGULANT TREATMENT.
- •\-DISCONFORM WITH INFORMED CONSENTIMENT.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Clinical trial to evaluate efficacy and safety of low molecular collagen peptides for joint paiKCT0007584Yonsei University Health System, Severance Hospital78
Completed
Phase 3
Clinical trial to evaluate efficacy and safety of KCS03 stent in a native coronary lesioStable angina, unstable angina and non-ST elevated myocardial infarction with de novo or restenotic coronary lesionsJPRN-UMIN000010422Kaneka Corporation115
Completed
Phase 2
Clinical trial to evaluate efficacy and safety of cyclophosphamide, bortezomib and dexamethasone (CBD) induction and autologous stem cell transplantation for patients for newly diagnosed multiple myeloma (NBMT-ASCT1201)multiple myelomaJPRN-UMIN000008399Toyohashi Municipal Hospital Division of Hematology and Oncology54
Completed
Phase 3
Clinical trial to evaluate efficacy and safety of apheresis therapy on peripheral arterial disease with critical limb ischemia.Peripheral arterial diseaseJPRN-UMIN000020336Kaneka Corporation61
Recruiting
Phase 3
Clinical trial to evaluate safety and efficacy of radiofrequency ablation for malignant tumors located outside the livermalignant tumors which have lesions located outside the liverJPRN-UMIN000012109Division of Diagnostic Imaging and Minimally Invasive Therapy, Juntendo University Graduate School of Medicine20